NCT03086642 Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT03080935 Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries Status TERMINATED Phase PHASE3
NCT03072771 Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE1
NCT03070002 Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells Status TERMINATED Phase PHASE2
NCT03069378 A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03064763 Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma Status COMPLETED Phase PHASE1
NCT03043950 Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) Status COMPLETED Phase N/A
NCT03029234 Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT03023878 Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT03000374 Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery Status COMPLETED Phase PHASE2
NCT02994927 A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Status COMPLETED Phase PHASE3
NCT02993120 Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States Status COMPLETED Phase N/A
NCT02990104 First Report, Five Years Experience of the Acute Leukemia Work Group Status UNKNOWN Phase N/A
NCT02986139 Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02983097 Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP Status TERMINATED Phase PHASE1/PHASE2
NCT02970747 Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients Status COMPLETED Phase N/A
NCT02969837 Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02961881 A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1